Women who participated in the paid labor force have lower rates of memory decline
Working to remember
Citation Manager Formats
Make Comment
See Comments
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Despite a move toward precision medicine approaches to cognitive impairment and dementia, the incorporation of sex and gender differences remains limited.1,2 Sex refers to biological differences such as chromosomal, gonadal, or hormonal differences; gender refers to a combination of environmental, social, and cultural influences on women and men.3 Gender is rooted in biology but shaped by environment and experience. Of studies in the dementia field that have incorporated sex and gender, the vast majority focus on sex differences or sex-specific factors including pregnancy, the menopausal transition and use of hormone therapy, genetics, or differences in biomarker profiles.1 Fewer studies have focused on gender-related differences in dementia risk, with education the factor most examined.2 Low education is associated with risk of dementia in both women and men, but women born in the 20th century have historically had less access to education than men; thus, this risk factor has had a proportionally greater effect on older women. There has been even less research, if any, on gender differences in occupation or workforce participation for late-life cognitive outcomes. This is particularly relevant for women because life course patterns of working, childrearing, and marriage have changed dramatically over the last century, with an increasing number of women joining the paid labor force. Studies demonstrating that lifetime occupational attainment4 and occupational complexity are related to cognitive decline and dementia risk have largely overlooked this historical gender discrepancy.5
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the editorial.
See page 1031
- © 2020 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Costs and Utilization of New-to-Market Neurologic Medications
Dr. Robert J. Fox and Dr. Mandy Leonard
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Editorial
Past hormone therapy in older womenDoes the brain recover from adverse effects?Kejal Kantarci, Pauline M. Maki et al.Neurology, January 02, 2014 -
Article
Postmenopausal hormone therapy and Alzheimer diseaseA prospective cohort studyBushra Imtiaz, Marjo Tuppurainen, Toni Rikkonen et al.Neurology, February 15, 2017 -
Article
Association of work-family experience with mid- and late-life memory decline in US womenElizabeth Rose Mayeda, Taylor M. Mobley, Robert E. Weiss et al.Neurology, November 04, 2020 -
Articles
Hormone therapy and Alzheimer disease dementiaNew findings from the Cache County StudyHuibo Shao, John C.S. Breitner, Rachel A. Whitmer et al.Neurology, October 24, 2012